Skip to main content

Table 1 Demographics and safety of H1N1 vaccine administration to study groups

From: Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients

 

Patients with Egg allergy

Control Subjects

Number of patients

59

10

Age in years (mean)

1-27(5.6)

13-77(45.5)

Male sex (percentage)

41(69.5%)

1(12.5%)

Positive skin test response to H1N1 vaccine

1

0

Reaction post-vaccination

None

None

Exact 95% Confidence Interval for percentage who can safely receive this vaccine

90.23%, 99.67%

63.06%, 100%